Back to calendar
BridgeBio Pharma, Inc. (BBIO) Earnings
BBIO reports earnings on Monday, August 10, 2026
earnings report
August 10, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.58
Actual EPS: $-0.84
EPS surprise: -23.75%
Company overview
Market Cap$16.2B
PriceUSD 82.71
EPS (TTM)-3.75
52-week high93.42
52-week low44.10
SectorHealth Technology
IndustryBiotechnology
Employees839